Cargando…

Inhibition of neutral sphingomyelinase 2 promotes remyelination

Myelination requires a highly organized synthesis of multiple lipid species that regulate myelin curvature and compaction. For reasons that are not understood, central nervous system remyelinated axons often have thin myelin sheaths with a disorganized structure susceptible to secondary demyelinatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Seung-Wan, Agarwal, Amit, Smith, Matthew D., Khuder, Saja S., Baxi, Emily G., Thomas, Ajit G., Rojas, Camilo, Moniruzzaman, Mohammed, Slusher, Barbara S., Bergles, Dwight E., Calabresi, Peter A., Haughey, Norman J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852391/ https://www.ncbi.nlm.nih.gov/pubmed/33008902 http://dx.doi.org/10.1126/sciadv.aba5210

Ejemplares similares

Cambinol, a Novel Inhibitor of Neutral Sphingomyelinase 2 Shows Neuroprotective Properties
por: Figuera-Losada, Mariana, et al.
Publicado: (2015)

Neutral sphingomyelinase 2 inhibition attenuates extracellular vesicle release and improves neurobehavioral deficits in murine HIV
por: Zhu, Xiaolei, et al.
Publicado: (2022)

Inhibition of neutral sphingomyelinase 2 impairs HIV-1 envelope formation and substantially delays or eliminates viral rebound
por: Yoo, Seung-Wan, et al.
Publicado: (2023)

DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation
por: Rojas, Camilo, et al.
Publicado: (2018)

Remyelination alters the pattern of myelin in the cerebral cortex
por: Orthmann-Murphy, Jennifer, et al.
Publicado: (2020)

Neutral Sphingomyelinase and Breast Cancer Research
por: Hwang, Sun-Yong, et al.
Publicado: (2015)

Neutral sphingomyelinase‐2 and cardiometabolic diseases
por: Sindhu, Sardar, et al.
Publicado: (2021)

Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls
por: Lea, Simon R, et al.
Publicado: (2016)

Netupitant and palonosetron trigger NK(1) receptor internalization in NG108-15 cells
por: Thomas, Ajit G., et al.
Publicado: (2014)

Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis
por: Gharagozloo, Marjan, et al.
Publicado: (2022)

Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction
por: Cogolludo, Angel, et al.
Publicado: (2009)

Neutral Sphingomyelinase in Physiological and Measles Virus Induced T Cell Suppression
por: Mueller, Nora, et al.
Publicado: (2014)

The Activity of the Neutral Sphingomyelinase Is Important in T Cell Recruitment and Directional Migration
por: Collenburg, Lena, et al.
Publicado: (2017)

Characterization of a Neutral Sphingomyelinase Activity in Human Serum and Plasma
por: Mühle, Christiane, et al.
Publicado: (2023)

Holotoxin A(1) Induces Apoptosis by Activating Acid Sphingomyelinase and Neutral Sphingomyelinase in K562 and Human Primary Leukemia Cells
por: Yun, Seong-Hoon, et al.
Publicado: (2018)

Neutral sphingomyelinase 2 modulates cytotoxic effects of protopanaxadiol on different human cancer cells
por: Park, Bonggoo, et al.
Publicado: (2013)

Astrocytes deliver CK1 to neurons via extracellular vesicles in response to inflammation promoting the translation and amyloidogenic processing of APP
por: Li, Zhigang, et al.
Publicado: (2020)

A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization
por: Khavandgar, Zohreh, et al.
Publicado: (2011)

Neutral sphingomyelinases control extracellular vesicles budding from the plasma membrane
por: Menck, Kerstin, et al.
Publicado: (2017)

The Neutral Sphingomyelinase 2 Is Required to Polarize and Sustain T Cell Receptor Signaling
por: Börtlein, Charlene, et al.
Publicado: (2018)

Neutral sphingomyelinase inhibition promotes local and network degeneration in vitro and in vivo
por: Risner, Michael L., et al.
Publicado: (2023)

Tracking the evolution of CNS remyelinating lesion in mice with neutral red dye
por: Baydyuk, Maryna, et al.
Publicado: (2019)

Molecular modeling of human neutral sphingomyelinase provides insight into its molecular interactions
por: Dinesh,, et al.
Publicado: (2011)

Neutral sphingomyelinase-3 mediates TNF-stimulated oxidant activity in skeletal muscle
por: Moylan, Jennifer S., et al.
Publicado: (2014)

Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase–ceramide pathway
por: Lee, Jiunn-Tay, et al.
Publicado: (2004)

Primary cilia in stem cells and neural progenitors are regulated by neutral sphingomyelinase 2 and ceramide
por: He, Qian, et al.
Publicado: (2014)

Niemann-Pick Type A Disease: Behavior of Neutral Sphingomyelinase and Vitamin D Receptor
por: Conte, Carmela, et al.
Publicado: (2019)

Neutral sphingomyelinase 2 regulates inflammatory responses in monocytes/macrophages induced by TNF-α
por: Al-Rashed, Fatema, et al.
Publicado: (2020)

Vascular Smooth Muscle Cell Neutral Sphingomyelinase 2 in the Release of Exosomes and Vascular Calcification
por: Pavlic, Angelina, et al.
Publicado: (2022)

Molecular basis for the catalytic mechanism of human neutral sphingomyelinases 1 (hSMPD2)
por: Yi, Jingbo, et al.
Publicado: (2023)

Remyelination as Neuroprotection
por: Howe, Charles L., et al.
Publicado: (2005)

Erratum to: Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination
por: Syed, Yasir A., et al.
Publicado: (2016)

Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects
por: Kalinichenko, Liubov S., et al.
Publicado: (2021)

Oligodendrocytes control potassium accumulation in white matter and seizure susceptibility
por: Larson, Valerie A, et al.
Publicado: (2018)

Sphingomyelinases and Liver Diseases
por: Insausti-Urkia, Naroa, et al.
Publicado: (2020)

Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination
por: Syed, Yasir A., et al.
Publicado: (2015)

The essential neutral sphingomyelinase is involved in the trafficking of the variant surface glycoprotein in the bloodstream form of Trypanosoma brucei
por: Young, Simon A, et al.
Publicado: (2010)

Inhibition of neutral sphingomyelinases in skeletal muscle attenuates fatty-acid induced defects in metabolism and stress
por: Verma, Mahesh Kumar, et al.
Publicado: (2014)

P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest
por: Shamseddine, A A, et al.
Publicado: (2015)

Neutral sphingomyelinase (SMPD3) deficiency disrupts the Golgi secretory pathway and causes growth inhibition
por: Stoffel, Wilhelm, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u6ja6ktvr4bmka0q6eae4rc6np